| Technical report on critical concentrations for drug susceptibility testing of medicines used in the treatment of drug-resistant tuberculosis World Health Organization World Health Organization, 2018 | 374 | 2018 |
| Prediction of susceptibility to first-line tuberculosis drugs by DNA sequencing CRyPTIC Consortium and the 100,000 Genomes Project New England Journal of Medicine 379 (15), 1403-1415, 2018 | 335 | 2018 |
| The use of lateral flow urine lipoarabinomannan assay (LF-LAM) for the diagnosis and screening of active tuberculosis in people living with HIV: policy guidance World Health Organization World Health Organization, 2015 | 243 | 2015 |
| Population-based resistance of Mycobacterium tuberculosis isolates to pyrazinamide and fluoroquinolones: results from a multicountry surveillance project M Zignol, AS Dean, N Alikhanova, S Andres, AM Cabibbe, DM Cirillo, ... The Lancet infectious diseases 16 (10), 1185-1192, 2016 | 210 | 2016 |
| Genetic sequencing for surveillance of drug resistance in tuberculosis in highly endemic countries: a multi-country population-based surveillance study M Zignol, AM Cabibbe, AS Dean, P Glaziou, N Alikhanova, C Ama, ... The Lancet Infectious Diseases 18 (6), 675-683, 2018 | 159 | 2018 |
| The 2021 WHO catalogue of Mycobacterium tuberculosis complex mutations associated with drug resistance: a genotypic analysis TM Walker, P Miotto, CU Köser, PW Fowler, J Knaggs, Z Iqbal, M Hunt, ... The Lancet Microbe 3 (4), e265-e273, 2022 | 149 | 2022 |
| Antibiotic resistance prediction for Mycobacterium tuberculosis from genome sequence data with Mykrobe M Hunt, P Bradley, SG Lapierre, S Heys, M Thomsit, MB Hall, KM Malone, ... Wellcome open research 4, 2019 | 124 | 2019 |
| Prevalence and genetic profiles of isoniazid resistance in tuberculosis patients: A multicountry analysis of cross-sectional data AS Dean, M Zignol, AM Cabibbe, D Falzon, P Glaziou, DM Cirillo, ... PLoS medicine 17 (1), e1003008, 2020 | 108 | 2020 |
| Population based national tuberculosis prevalence survey among adults (> 15 years) in Pakistan, 2010–2011 E Qadeer, R Fatima, A Yaqoob, S Tahseen, M Ul Haq, A Ghafoor, M Asif, ... PloS one 11 (2), e0148293, 2016 | 96 | 2016 |
| Population structure, biogeography and transmissibility of Mycobacterium tuberculosis L Freschi, R Vargas Jr, A Husain, SMM Kamal, A Skrahina, S Tahseen, ... Nature communications 12 (1), 6099, 2021 | 86 | 2021 |
| Extrapulmonary tuberculosis in Pakistan-A nation-wide multicenter retrospective study S Tahseen, FM Khanzada, AQ Baloch, Q Abbas, MM Bhutto, AW Alizai, ... PloS one 15 (4), e0232134, 2020 | 78 | 2020 |
| Acquisition of cross-resistance to bedaquiline and clofazimine following treatment for tuberculosis in Pakistan A Ghodousi, AH Rizvi, AQ Baloch, A Ghafoor, FM Khanzada, M Qadir, ... Antimicrobial agents and chemotherapy 63 (9), 10.1128/aac. 00915-19, 2019 | 66 | 2019 |
| Characterization of genomic variants associated with resistance to bedaquiline and delamanid in naive Mycobacterium tuberculosis clinical strains S Battaglia, A Spitaleri, AM Cabibbe, CJ Meehan, C Utpatel, N Ismail, ... Journal of clinical microbiology 58 (11), 10.1128/jcm. 01304-20, 2020 | 55 | 2020 |
| Delay in diagnosis of tuberculosis in Rawalpindi, Pakistan MAN Saqib, IN Awan, SKA Rizvi, MI Shahzad, ZS Mirza, S Tahseen, ... BMC research notes 4, 1-5, 2011 | 55 | 2011 |
| A data compendium associating the genomes of 12,289 Mycobacterium tuberculosis isolates with quantitative resistance phenotypes to 13 antibiotics CRyPTIC Consortium PLoS biology 20 (8), e3001721, 2022 | 52 | 2022 |
| Role of epistasis in amikacin, kanamycin, bedaquiline, and clofazimine resistance in Mycobacterium tuberculosis complex R Vargas Jr, L Freschi, A Spitaleri, S Tahseen, I Barilar, S Niemann, ... Antimicrobial Agents and Chemotherapy 65 (11), 10.1128/aac. 01164-21, 2021 | 51 | 2021 |
| Use of Xpert® MTB/RIF assay in the first national anti-tuberculosis drug resistance survey in Pakistan S Tahseen, E Qadeer, FM Khanzada, AH Rizvi, A Dean, A Van Deun, ... The International Journal of Tuberculosis and Lung Disease 20 (4), 448-455, 2016 | 49 | 2016 |
| Epidemiological cut-off values for a 96-well broth microdilution plate for high-throughput research antibiotic susceptibility testing of M. tuberculosis CRyPTIC Consortium European Respiratory Journal 60 (4), 2022 | 47 | 2022 |
| Plasma antibody profiles as diagnostic biomarkers for tuberculosis IH Khan, R Ravindran, VV Krishnan, IN Awan, SK Rizvi, MA Saqib, ... Clinical and Vaccine Immunology 18 (12), 2148-2153, 2011 | 46 | 2011 |
| Evaluation of a novel line probe assay to detect resistance to pyrazinamide, a key drug used for tuberculosis treatment M Driesen, Y Kondo, BC de Jong, G Torrea, S Asnong, C Desmaretz, ... Clinical Microbiology and Infection 24 (1), 60-64, 2018 | 34 | 2018 |
